Critical Illness / AIA Financial Indonesia
AIA Sehat Seratus
AIA Sehat Seratus is a comprehensive critical-illness product covering 136 conditions structured as a lump-sum payer with a distinctive multi-stage design: 100% sum assured for major CI diagnosis (then policy continues 12 months for overse…
★ The Insurer’s Play
analytical interpretationWhy this product exists
To sell lump-sum protection against a small set of high-cost diagnoses — specifically, to capture whole-household budgets rather than single lives and use a loyalty mechanic to improve persistency and perceived value.
What the insurer wants the agent to do
Steer the agent to bundle several family members onto one policy, lead with the no-claim cashback / loyalty bonus, and attach and upsell supplementary riders.
Inferred from: family-package structureno-claim cashback / loyalty mechanicrider attachmentunit-linked / PAYDI designPOJK 36/2025 co-paymentaffluent / legacy segment
Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.
Who this fits — and who it doesn’t
✓ Fits when…
- Age 30–50, employed or self-employed, stable income
- Monthly disposable income Rp 4M–10M+ (mass affluent), can comfortably carry Rp 17.9M+ annual premium
- Already has basic health insurance (HMO or separate policy) — this is the critical event layer, not the hospitalization layer
- Cancer risk awareness (family history, age cohort concern) or cardiac event anxiety in mid-40s+
- Values comprehensive protection over cost minimization; willing to pay premium for multi-stage safety nets
- Health-conscious or engaged with wellness programs (Vitality Program uptake suggests organized approach to health)
- Possible overseas access (for cancer/heart treatment abroad) or planning for children's education overseas
- Prefers flexible payment terms (5/10/20 years) so can close payment window in earning peak years
~ Borderline — qualify carefully
- Age 50–60 — premium loads heavily; only 5-year payment term available (no 10/20). Doable if customer is high-income and doesn't mind premium concentration. Probe if 5-year is viable before pitching booster benefits.
- Young entrants (25–30) — product works, but entry below 30 may not trigger urgent CI concern. Lead with "prevention + protection" narrative rather than "crisis hedging."
- Existing health conditions (managed diabetes, hypertension) — full underwriting applies; may face postponement, loading, or exclusions. Require medical clearance before quoting.
- Self-employed with volatile income — probe sustainability of Rp 17.9M annual commitment; lapse risk in year 3–5 is material.
- Customers with young children (unborn child benefit interest) — product offers unborn child protection (reduced benefit 0–90 days, full benefit 90+ days), but this requires careful enrollment windowing.
✕ Not a fit when…
- Mass middle market below Rp 3M monthly disposable income — minimum premium floor prices them out
- Customers whose primary need is hospitalization reimbursement — they need health insurance first, not CI
- Prospects with no health insurance and unreliable healthcare access — CI is worthless without ability to diagnose and treat
- Elderly or late-life prospects (60+) — renewal premiums become prohibitive; product philosophy assumes mid-to-peak earning years
- Customers unwilling to engage with Vitality Program or digital tools — they lose the discount and cashback, paying 30% more for equal cover
- Anyone prioritizing permanent whole-life legacy (they are an LegacyPro or similar prospect, not CI)
- Customers with strong family history of genetic conditions — pre-existing condition exclusions may leave them exposed; probe carefully before quoting
The trade-offs — when it wins, when it doesn’t
No product wins for everyone. Here’s when AIA Sehat Seratus is the right call — and when a different product is.
WANTS MULTI-STAGE CI PROTECTION, CANCER ANXIETY, VALUES OVERSEAS ACCESS
Lead:Sehat Seratus
12-month overseas cancer/ heart treatment window is rare. Double cancer-recurrence claim is differentiator. Vitality cashback reward organized customers.
WANTS CI PROTECTION, PRICE-SENSITIVE, WANTS SINGLE-STAGE SIMPLICITY
Lead:Allianz Critical Plus
Lower annual premium (Rp 27.9M vs Sehat Seratus Rp 17.9M for lower SA range is comparable, but Allianz has 50% booster if organized). Simpler two-tier structure.
WANTS CI PROTECTION, PREFERS INVESTMENT UPSIDE
Lead:Smartlink CI or unit-linked CI rider
Zero investment component in Sehat Seratus. Competitors offer market-linked upside.
WANTS PERMANENT LEGACY WITH CI PREMIUM WAIVER
Lead:LegacyPro (Allianz)
Whole-life to age 100, premium waiver at diagnosis. Sehat Seratus is term-based, ends at age 99.
WANTS PURE INCOME PROTECTION, LOWEST COST
Lead:Term life (Smartlife Maxima Plus)
5–10x cheaper premium for pure death benefit. No CI, no layering.
WANTS CONDITION-SPECIFIC CI (CANCER ONLY)
Lead:Mandiri Proteksi Kanker or Allianz Smartlink Cancer
Narrower scope, lower cost. Sehat Seratus is broad (136 conditions), so overkill for cancer-only concern.
WANTS FAMILY PROTECTION DURING PREGNANCY / UNBORN CHILD BENEFIT
Lead:Sehat Seratus (unborn child rider) or health insurance with maternity
Sehat Seratus unborn child benefit is available but layered (reduced benefit if claim within 90 days of birth). Health insurance is primary.
HIGH INCOME, WANTS MAXIMUM COVERAGE + FLEXIBILITY
Lead:Sehat Seratus with high SA option
Maximum SA Rp 10B for adults. Flexible payment terms (5/10/20). Vitality Program for ongoing engagement.
Key facts
Coverage
- Sum assured: Uang Pertanggungan, termasuk penggantian biaya perjalanan senilai USD 200
- Policy term: not disclosed on page
- Pricing: not disclosed on page
Target Customer
Not specified on page.
Key Features
- Asuransi Jiwa AIA Melangkah Bersama AIA PowerPro Life Optima Protection Plus Proteksi Jiwa Maksima (JIMI) AIA Nura Journ
- AIA Melangkah Bersama
- AIA PowerPro Life
- Optima Protection Plus
⚠ Compliance red flags & mis-selling warnings
-
Pre-existing Conditions Exclusion (POJK 36/2025 alignment): The RIPLAY explicitly states that major CI, minor CI, angioplasty, ICU, and overseas treatment benefits are not paid if the condition is pre-existing or related to AIDS/HIV (except HIV-related critical illnesses listed in the policy appendix). Agents must verify underwriting responses before issuing. Do not accept vague health declarations. If a customer has existing diabetes, hypertension, or past cancer, flag for medical underwriting review before quoting. Mis-selling risk: agent quotes based on assumed health when customer has undisclosed conditions; claim is denied; customer blames agent.
-
Cancer Relapse Condition Specificity (Strict Definition): The RIPLAY states the second cancer claim (relapse benefit) requires “different histology AND pathology AND organ” from the first claim. If a customer is diagnosed with breast cancer, then ovarian cancer (different organ, same histological family), the second claim is payable. But if the second diagnosis is metastasis or recurrence of the first cancer (same histology/pathology in a new site), the relapse benefit does NOT pay. Agents must explain this limit clearly. Mis-selling risk: customer assumes “any cancer after 12 months = second claim payable” without understanding the histology requirement.
-
Vitality Program Behavioral Enforcement (Not Guaranteed Cashback): The Vitality Program cashback (Silver 2.5%, Gold 5%, Platinum 10%) is contingent on maintaining status throughout the policy year. If a customer falls below the required health activities (medical checkup, activity logging, non-smoking verification), their status drops and cashback is forfeited for that year. The discount (Year 1 only) is not conditional, but the ongoing cashback is. Do not position cashback as “guaranteed annual refund.” Frame it as “you earn cashback by staying engaged with your health plan.” Mis-selling risk: customer expects cashback in year 2 without effort, then claims agent promised automatic refund.
-
Unborn Child Rider Timing and Limits (Policy Amendment Required): The unborn child benefit requires that the child be registered as the insured within 90 days of birth, with submission of birth certificate. Benefits paid within 90 days of birth are reduced to 20% (major CI, minor CI, angioplasty, overseas treatment, ICU, death); benefits after 90 days are 100%. If the policy holder fails to register the child within the 90-day window, the rider lapses and the child is no longer covered. Agents must clarify this requirement upfront. Mis-selling risk: parent buys unborn child rider thinking automatic coverage starts at birth; child is born; parent is late registering; policy lapses; no coverage.
-
Surrender Value and Lapse Mechanics (Especially Years 1–3): The RIPLAY does not explicitly disclose a detailed surrender-value table for Sehat Seratus (unlike Allianz LegacyPro, which publishes surrender factors). Year 1–3 surrender values are expected to be low (typically 0–10% of premiums in conventional CI products). If a customer lapses in year 2 and wants to re-enter, full underwriting applies (not automatic re-acceptance). Agents must warn that early lapse recovery is difficult. Mis-selling risk: customer thinks lapse is reversible without penalty; lapses; finds re-entry requires new medical exams and possible exclusions.
-
Overseas Treatment Claim Documentation (Requires Pre-approval): The overseas cancer/heart treatment benefit requires that treatment occur within 12 months of major CI diagnosis, and covers “biaya perawatan” (treatment cost). The RIPLAY does not specify whether pre-approval from AIA is required or if reimbursement is post-treatment. Agents should advise customers to contact AIA before committing to expensive overseas treatment; failure to obtain approval may result in claim denial. Mis-selling risk: customer goes to Singapore for treatment without telling AIA, incurs Rp 500M cost, then AIA denies claim because treatment did not meet policy definition or approval requirements.
-
Accelerated vs. Non-Accelerated Benefit Confusion: The RIPLAY uses the term “benefit akselerasi” (accelerated benefit) for minor CI, angioplasty, and ICU catch-all. These benefits reduce the sum-assured pool for subsequent major CI, death, maturity, and surrender payouts. The ICU daily allowance (Rp 5M/day, max 4 days) is NOT accelerated (does not reduce pool). Agents must clarify this distinction when explaining scenarios. Mis-selling risk: customer assumes all benefits are independent; claims minor CI and ICU daily allowance; then is shocked that major CI is now worth 50% less.
Internal training guidance. Always confirm against the current RIPLAY/policy — the policy is the binding document.
Expert · technical detail
How Critical Illness products differ
Still building · 77% coverageNo product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.
- Most agency CI products are renewable-term structures (5/10/15-year periods) rather than whole-life CI cover.
- Early CI + Major CI + Premium Waiver triple-stack (Allianz pattern) is differentiating relative to single-stage products.
- Booster/return-of-premium tail benefits are increasingly standard for premium-tier CI.
- Sharia CI products follow conventional structure with Tabarru' / Wakalah bil Ujrah overlay.
- TMLI tm-ci-guard and tm-critical-guard are publishing-gap B set; lower confidence on full-feature comparison.
Coverage caveat: Critical-illness category is structurally heterogeneous: comprehensive CI lump-sum, early-stage CI add-ons, gender/condition-specific products, and recurring-payment CI. Aggregate quantitative benchmarking across these structures is misleading; sub-category qualitative comparison is preferred. Briefs rely on qualitative comparison plus direct PDF reading. (sample: ~23 products)
Expert · full Strategic Brief
1. The 60-Second Pitch
AIA Sehat Seratus is a comprehensive critical-illness product covering 136 conditions structured as a lump-sum payer with a distinctive multi-stage design: 100% sum assured for major CI diagnosis (then policy continues 12 months for overseas cancer/heart treatment), plus 25% payouts for early-stage minor CI (two claims allowed, one of which can be a repeat cancer if histologically different), plus incremental ICU daily allowance (Rp 5M per day, max 4 days/claim) before the 50% accelerated ICU catch-all kicks in (5+ days minimum). Paid-up options at 5/10/20 years mean customers can stop paying while staying covered to age 99. Optional Vitality Program layering provides first-year premium discount (2.5–7.5%) plus annual cashback (0–30% depending on status), rewarding ongoing health engagement.
In one line: A multi-stage safety net for early cancer scares and late-stage heart events, with built-in incentives to stay healthy and ongoing overseas-treatment coverage.
2. Headline Numbers Decoded (the brochure sample case)
The official AIA illustration uses Dita, 30yo female, Rp 500M sum assured, 10-year payment term, Rp 17.856M annual base premium + Rp 508.539 Payor Benefit CI rider = Rp 18.364.539 total. Vitality Program enrolled, Silver status. Decoded:
Critical insight for the agent narrative: Sehat Seratus is not a single-payout product. It is a layered event ladder — the policy continues through multiple claims until the SA is exhausted or a terminal major-CI event occurs. The 12-month overseas-treatment window after cancer/heart diagnosis is a rare and valuable feature for customers with means to seek treatment abroad. Frame it as “if the worst happens, we keep the door open for 12 months of follow-up care.”
TOTAL PREMIUM PAID (10 yrs)
Rp 178.6M base
What Dita hands AIA over
the payment window before
any Vitality discount.
YEAR 1 VITALITY DISCOUNT
5% x Rp 17.856M = Rp 892.8K
Dita's first-year premium
becomes Rp 16.964M.
Discount only applies to
Year 1 (2.5%, 5%, or 7.5%
depending on payment term).
ANNUAL CASHBACK (SILVER STATUS)
5% x Rp 17.856M = Rp 892.8K
Dita gets Rp 892.8K back each
year if she maintains Silver
status in Vitality Program.
Effective annual net cost:Rp 16.964M (Year 1 net).
MAJOR CI BENEFIT (100%)
Rp 500M
Paid if Dita is diagnosed
with one of 77 major conditions
(cancer, stroke, MI, etc.).
If diagnosis is cancer or heart,
policy stays active 12 months
for overseas treatment claims.
MINOR CI BENEFIT (25%, early stage)
Rp 125M (25% of SA)
Paid if Dita is diagnosed with
early-stage condition (e.g.,
early cancer, angioplasty).
Benefit is accelerated (reduces
SA pool for death benefit later).
Max 2 claims per policy term.
CANCER RECURRENCE BENEFIT
Rp 125M (second 25% payout)
Paid if Dita is diagnosed with
a DIFFERENT TYPE of cancer
(different histology/pathology
and organ) at least 12 months
after the first minor cancer
claim. Rare feature in CI space.
ICU DAILY ALLOWANCE
Rp 5M per day
Paid if Dita requires ICU with
ventilator support, min 6 hrs
= 1 day. Max 4 days per claim
(Rp 20M cap per incident).
No reduction to SA pool.
ACCELERATED ICU BENEFIT
Rp 250M (50% of SA,
or cap, whichever is less)
Paid if ICU stay exceeds
5 continuous days AND
requires ventilator. Reduces
SA pool. Max once per policy.
OVERSEAS CANCER/HEART
TREATMENT (12-month window)
50% of SA or Rp 250M max
Paid after Major CI claim if
treatment occurs within 12
months of diagnosis. Covers
treatment cost abroad
(e.g., Singapore hospital).
END-OF-POLICY BENEFIT
Rp 500M (100% of SA)
Paid if Dita reaches age 99
and no major CI/death benefit
has been claimed. Policy ends.
DEATH BENEFIT (unaccounted for)
100% of SA (Rp 500M) minus
any accelerated benefits
already paid. If Dita dies
without CI diagnosis, her
beneficiaries receive the
remaining pool.
ADDITIONAL ACCIDENT BENEFIT
100% of SA on top
Paid if Dita dies from
accident (does NOT reduce
SA pool for other benefits).
Premium waiver riders also
available (Payor Benefit CI,
Payor Benefit).
3. Ideal Customer Profile
Sweet Spot — Lead with Sehat Seratus
- Age 30–50, employed or self-employed, stable income
- Monthly disposable income Rp 4M–10M+ (mass affluent), can comfortably carry Rp 17.9M+ annual premium
- Already has basic health insurance (HMO or separate policy) — this is the critical event layer, not the hospitalization layer
- Cancer risk awareness (family history, age cohort concern) or cardiac event anxiety in mid-40s+
- Values comprehensive protection over cost minimization; willing to pay premium for multi-stage safety nets
- Health-conscious or engaged with wellness programs (Vitality Program uptake suggests organized approach to health)
- Possible overseas access (for cancer/heart treatment abroad) or planning for children’s education overseas
- Prefers flexible payment terms (5/10/20 years) so can close payment window in earning peak years
Borderline Fit — Discuss but qualify carefully
- Age 50–60 — premium loads heavily; only 5-year payment term available (no 10/20). Doable if customer is high-income and doesn’t mind premium concentration. Probe if 5-year is viable before pitching booster benefits.
- Young entrants (25–30) — product works, but entry below 30 may not trigger urgent CI concern. Lead with “prevention + protection” narrative rather than “crisis hedging.”
- Existing health conditions (managed diabetes, hypertension) — full underwriting applies; may face postponement, loading, or exclusions. Require medical clearance before quoting.
- Self-employed with volatile income — probe sustainability of Rp 17.9M annual commitment; lapse risk in year 3–5 is material.
- Customers with young children (unborn child benefit interest) — product offers unborn child protection (reduced benefit 0–90 days, full benefit 90+ days), but this requires careful enrollment windowing.
Do Not Pitch
- Mass middle market below Rp 3M monthly disposable income — minimum premium floor prices them out
- Customers whose primary need is hospitalization reimbursement — they need health insurance first, not CI
- Prospects with no health insurance and unreliable healthcare access — CI is worthless without ability to diagnose and treat
- Elderly or late-life prospects (60+) — renewal premiums become prohibitive; product philosophy assumes mid-to-peak earning years
- Customers unwilling to engage with Vitality Program or digital tools — they lose the discount and cashback, paying 30% more for equal cover
- Anyone prioritizing permanent whole-life legacy (they are an LegacyPro or similar prospect, not CI)
- Customers with strong family history of genetic conditions — pre-existing condition exclusions may leave them exposed; probe carefully before quoting
4. Decision Framework — When Sehat Seratus Beats the Alternatives
Rule of thumb: if the customer’s first sentence contains “takut kanker” (cancer fear), “luar negeri” (overseas), “olahraga” (health/fitness), or “tahun depan berhenti bayar” (want to stop paying soon), Sehat Seratus is in the conversation. If they prioritize cost over features or are searching for investment returns, lead with a competing product.
WANTS MULTI-STAGE CI PROTECTION, CANCER ANXIETY, VALUES OVERSEAS ACCESS
Lead:Sehat Seratus
12-month overseas cancer/ heart treatment window is rare. Double cancer-recurrence claim is differentiator. Vitality cashback reward organized customers.
WANTS CI PROTECTION, PRICE-SENSITIVE, WANTS SINGLE-STAGE SIMPLICITY
Lead:Allianz Critical Plus
Lower annual premium (Rp 27.9M vs Sehat Seratus Rp 17.9M for lower SA range is comparable, but Allianz has 50% booster if organized). Simpler two-tier structure.
WANTS CI PROTECTION, PREFERS INVESTMENT UPSIDE
Lead:Smartlink CI or unit-linked CI rider
Zero investment component in Sehat Seratus. Competitors offer market-linked upside.
WANTS PERMANENT LEGACY WITH CI PREMIUM WAIVER
Lead:LegacyPro (Allianz)
Whole-life to age 100, premium waiver at diagnosis. Sehat Seratus is term-based, ends at age 99.
WANTS PURE INCOME PROTECTION, LOWEST COST
Lead:Term life (Smartlife Maxima Plus)
5–10x cheaper premium for pure death benefit. No CI, no layering.
WANTS CONDITION-SPECIFIC CI (CANCER ONLY)
Lead:Mandiri Proteksi Kanker or Allianz Smartlink Cancer
Narrower scope, lower cost. Sehat Seratus is broad (136 conditions), so overkill for cancer-only concern.
WANTS FAMILY PROTECTION DURING PREGNANCY / UNBORN CHILD BENEFIT
Lead:Sehat Seratus (unborn child rider) or health insurance with maternity
Sehat Seratus unborn child benefit is available but layered (reduced benefit if claim within 90 days of birth). Health insurance is primary.
HIGH INCOME, WANTS MAXIMUM COVERAGE + FLEXIBILITY
Lead:Sehat Seratus with high SA option
Maximum SA Rp 10B for adults. Flexible payment terms (5/10/20). Vitality Program for ongoing engagement.
5. Product Benchmarking — Sehat Seratus vs the Critical-Illness Category
The critical-illness category comprises 26 agency-channel products across 11 insurers, with structural diversity spanning comprehensive CI lump-sum (Allianz Critical Plus, AIA Vital Care, Sehat Seratus), early-stage CI add-ons, gender-specific products, and recurring-payment models. Quantitative benchmarking is below 60% coverage; qualitative comparison and direct PDF reading are primary. Below is a descriptive positioning:
STRUCTURAL DIMENSIONS
POLICY TERM STRUCTURE
Category typical:20-year term, auto-renewable; some fixed-term or whole-life CI riders
Sehat Seratus:Fixed term to age 99 (open-ended); pay 5/10/20 years, then covered to 99
Read:Unique structure. Most competitors use 20-year renewable or fixed-to-age. Sehat Seratus design assumes customer will reach 99 (beneficiary pays zero after paid-up period). Longer coverage horizon than most competitors.
COVERAGE SCOPE (CI CONDITIONS)
Category typical:20–80 conditions, often tiered early/major
Sehat Seratus:136 total conditions: 77 major (100%) 58 minor (25%) + angioplasty
Read:Upper quartile for breadth. Allianz Critical Plus lists ~90; Mandiri Secure lists 25. Sehat Seratus is among the broadest in the agency-channel space.
EARLY CI CLAIMS STRUCTURE
Category typical:1–2 claims per term, 25–50% payout
Sehat Seratus:2 claims allowed: (a) Minor CI 25% (b) Cancer relapse (if different histology/organ, 12+ months after first claim)
Read:The cancer-relapse mechanic is rare and differentiating. Most competitors allow 1 early claim. Sehat Seratus says "we expect you to survive early cancer and manage second-event risk." Reflects improving cancer-survival outcomes.
PREMIUM WAIVER
Category typical:Often a rider, paid separately; waives on CI diagnosis
Sehat Seratus:Automatic waiver not explicit in base product; offered as optional Payor Benefit rider (CI version + death/ disability version)
Read:Weaker integration than Allianz (which builds waiver into base). Sehat Seratus requires add-on rider purchase. Slight friction in bundling.
ICU BENEFITS
Category typical:Some; usually daily allowance or catch-all
Sehat Seratus:Dual structure: (a) Rp 5M daily allowance, min 6 hrs = 1 day, max 4 days/claim (Rp 20M cap) (b) 50% SA catch-all at 5+ days, max Rp 250M
Read:Sophisticated dual-tier design. Many competitors skip ICU benefits entirely. Sehat Seratus recognizes ICU cost impact (ventilator support). Catch-all feature incentivizes timely intervention.
OVERSEAS TREATMENT BENEFIT
Category typical:Rare; mostly IDR-focused products
Sehat Seratus:50% SA or Rp 250M max, 12-month window after major CI (cancer/heart)
Read:Differentiating feature. Few agency CI products offer overseas treatment coverage. Signals positioning toward affluent/HNW segment with cross-border medical access.
VITALITY / BEHAVIORAL INCENTIVE
Category typical:Increasingly common (Allianz, AIA, Prudential)
Sehat Seratus:Integrated Vitality Program: Year 1 discount (2.5–7.5% depending on payment term); annual cashback (0–30% depending on Vitality status)
Read:Strong behavioral lever. Customers at Silver+ status recover 5–30% of annual premium as cashback, reducing effective cost. Requires ongoing health engagement (checkup, activity logging, no smoking). Competitive feature among tier-1 insurers.
MINIMUM SUM ASSURED
Category typical:Rp 100M–500M range (wide variation)
Sehat Seratus:Rp 100M min; Rp 3B max (child); Rp 10B max (adult)
Read:Accessible floor (Rp 100M) is below some competitors (Allianz min Rp 200M). Ceiling (Rp 10B adult) is at top of range. Flexible SA scaling.
ENTRY AGE RANGE
Category typical:18–65 (most common)
Sehat Seratus:1 month – 60 yrs
Read:Broadest range in the sample. Includes infant protection (via unborn-child rider, transitioning at birth). Elderly cutoff (60) is in line with category but product design prefers mid-to-peak-earning entry.
ECONOMIC DIMENSIONS
DEATH BENEFIT MECHANIC
Category typical:Often 100% SA or 150–200% of premiums
Sehat Seratus:100% SA minus accelerated benefits paid; plus 100% accident bonus (does NOT reduce pool)
Read:Standard. Accident bonus is a common sweetener. The reduction-from-pool design is typical; limits customer confusion.
END-OF-CONTRACT BENEFIT
Category typical:50–100% of premiums paid, or zero
Sehat Seratus:100% SA (= maturity benefit at age 99)
Read:Generous. If customer reaches age 99 without major CI or death, they collect 100% SA as endowment. Very long tail (30–40 year horizon for age-50 entry).
RETURN-OF-PREMIUM STRUCTURE
Category typical:Some offer ROP, others zero
Sehat Seratus:No explicit ROP; 100% maturity benefit (SA at 99) is the tail benefit
Read:Different philosophy: instead of "refund your premiums if nothing happens," Sehat Seratus says "if you live to 99, you get your full sum assured." Longer time horizon required to break even on premiums vs. ROP structure.
PREMIUM COMMITMENT WINDOW
Category typical:20-year renewable is standard
Sehat Seratus:5, 10, or 20 year payment options with coverage to 99
Read:Flexibility on payment term is a strength. Customer can choose 5-year concentration in peak earning years, then coast to 99. Allianz Critical Plus offers similar 5/10/15 flexibility.
POSITIONING SUMMARY
On STRUCTURAL design, Sehat Seratus
scores in the top quartile of the
critical-illness category
136
conditions, cancer-relapse mechanic
(rare), dual-tier ICU structure, 12-
month overseas treatment window, and
integrated Vitality Program. Coverage
horizon to age 99 (post-paid-up) is
among the longest in the sample.
On ECONOMIC terms, the 100% maturity
benefit at age 99 is generous but
requires a 30–40 year commitment from
entry age. Upfront cost (Rp 17.9M
annually) is mid-range for the
category but competes favorably if
Vitality cashback is claimed
(effective cost drops to Rp 16.9M
Year 1, then Rp 17M + cashback).
On CLAIMS MECHANICS, the cancer-
relapse structure (two early CI
claims) is sophisticated and reflects
modern CI underwriting (recognize
that some customers survive early
cancer). The ICU catch-all (50% at
5+ days) is targeted at ventilator-
support scenarios and complements
the daily allowance.
LIMITATIONS
Payor Benefit (premium
waiver) is a separate rider, not
built into base (unlike Allianz
Critical Plus, which includes waiver
in base). Vitality Program requires
ongoing health engagement (checkup,
activity logging) to earn cashback
above Bronze tier (zero). Customers
who disengage drop to 0% cashback.
COMPETITIVE WINS
Overseas treatment
window (12 months post-major-CI) is
rare and valuable for HNW customers.
Cancer-relapse claim mechanic is
differentiating vs. single-claim
competitors. Flexible payment terms
(5/10/20) support mid-to-peak-earning
customer profiles. Broad condition
count (136) appeals to health-
anxious customers.
COMPETITIVE LOSSES
No built-in
premium waiver in base (must buy
rider). Maturity benefit (100% SA
at 99) has low actuarial probability
if entry is above age 50; may feel
irrelevant to customer. Vitality
Program is behavioral lever, not
guarantee (customers must engage).
6. Field Talking Points (EN + ID)
Customer-facing script — use the EN / ID toggle (top-right) to switch language.
Opening — establish the frame
“Do you have health insurance? Good. Now, health insurance covers your doctor visits and hospital stays. What it doesn’t cover is what happens to your family if you’re diagnosed with cancer, or if you have a heart attack and can’t work for six months — that’s the gap. Sehat Seratus steps into that gap.”
“Anda punya asuransi kesehatan? Bagus. Sekarang, asuransi kesehatan itu cover kunjungan dokter dan rawat inap. Yang tidak tercakup adalah apa yang terjadi pada keluarga Anda kalau terdiagnosa kanker, atau kalau serangan jantung dan tidak bisa kerja enam bulan — itu celahnya. Sehat Seratus masuk ke celah itu.”
The multi-stage structure (close the ladder)
“Here’s how it works. First, if you get early-stage cancer — caught early — you get 25% of your sum assured. That money comes fast, no waiting for surgery or treatment approvals. Then, if it gets more serious, you get 100% of your sum assured. The policy doesn’t end right away. It stays active for 12 months so you can explore treatment options, including overseas if needed.”
“Begini caranya. Pertama, kalau terdiagnosa kanker tahap awal — tertangkap awal — Anda dapat 25% dari Uang Pertanggungan. Uang itu datang cepat, tidak perlu tunggu operasi atau approval treatment. Kedua, kalau lebih serius, dapat 100% dari Uang Pertanggungan. Polis tidak langsung selesai. Tetap aktif 12 bulan jadi Anda bisa explore pilihan treatment, termasuk di luar negeri kalau perlu.”
The cancer-recurrence feature (sophisticated edge)
“One more thing — and this matters for women especially. If you get cancer once, survive it, and then get a different type of cancer down the road, we pay again. Not many products do that. We do, because we know cancer survival is improving, and you need protection for that second-event scenario.”
“Satu lagi — dan ini penting terutama untuk wanita. Kalau terdiagnosa kanker sekali, sembuh, terus terdiagnosa jenis kanker berbeda beberapa tahun kemudian, kami bayar lagi. Tidak banyak produk yang begini. Kami begini, karena kami tahu survival kanker meningkat, dan Anda butuh proteksi untuk scenario event kedua.”
The Vitality engagement layer
“We’ve added a wellness program called Vitality. The idea is simple: if you’re checking your health regularly, exercising, not smoking, we reward you with cashback every year. Over a 10-year payment period, that cashback can add up to 5-30% of your premium back in your pocket, depending on how engaged you are.”
“Kami tambahkan program wellness bernama Vitality. Idenya sederhana: kalau Anda check kesehatan regular, olahraga, tidak merokok, kami reward dengan cashback setiap tahun. Dalam periode pembayaran 10 tahun, cashback bisa jadi 5-30% dari premi balik ke kantong Anda, tergantung berapa engaged Anda.”
The overseas-access narrative (for HNW/cross-border segment)
“If you’re diagnosed with major cancer or heart disease, and you choose to get treatment in Singapore or overseas, the policy covers up to 50% of your sum assured for that treatment — for 12 months after diagnosis. That’s a safety net many Indonesian policies don’t offer.”
“Kalau terdiagnosa kanker atau penyakit jantung major, dan Anda pilih treatment di Singapura atau luar negeri, polis cover sampai 50% dari Uang Pertanggungan untuk treatment itu — selama 12 bulan setelah diagnosis. Itu safety net yang banyak polis Indonesia tidak offer.”
Closing — the long horizon
“You pay for 10 years during your earning peak. After that, you’re covered all the way to age 99 — no more premiums. If you reach 99 without a major event, you collect 100% of your sum assured. That’s a long-term commitment, but it’s structured for your reality, not the insurer’s convenience.”
“Anda bayar 10 tahun selama peak earning. Setelah itu, tertanggung sampai usia 99 — tidak perlu bayar lagi. Kalau sampai usia 99 tanpa major event, dapat 100% dari Uang Pertanggungan. Itu komitmen jangka panjang, tapi terstruktur untuk realitas Anda, bukan convenience perusahaan asuransi.”
—
7. Top 5 Customer Objections + Handling
Customer-facing script — use the EN / ID toggle (top-right) to switch language.
Objection 1: “Why should I pay Rp 17.9M a year if I’m young and healthy?”
Customer “Kenapa saya harus bayar Rp 17.9 juta per tahun kalau saya muda dan sehat?”
Don't say “Because you never know when you’ll get sick.” / “It’s an investment in your future.” / “Prevention is better than cure.”
Don't say “Karena Anda tidak tahu kapan sakit.” / “Ini investasi untuk masa depan Anda.” / “Pencegahan lebih baik daripada obat.”
Do say “You’re right — you’re healthy now. That’s exactly why this is affordable at your age. The premium is locked in based on your health today. In five years, if your health situation changes, your premium doesn’t go up. You’ve already locked in the best rate. And if you stay healthy, the Vitality Program gives you cash back every year to offset your cost.”
Do say “Anda benar — Anda sehat sekarang. Itulah kenapa biayanya terjangkau di usia Anda. Premi dikunci berdasarkan kesehatan Anda hari ini. Lima tahun dari sekarang, kalau situasi kesehatan berubah, premi Anda tidak naik. Anda sudah lock rate terbaik. Dan kalau tetap sehat, Vitality Program kasih cashback setiap tahun untuk offset biaya Anda.”
—
Objection 2: “I have BPJS. Isn’t that enough for critical illness?”
Customer “Saya punya BPJS. Itu sudah cukup untuk penyakit kritis?”
Don't say “BPJS is terrible.” / “BPJS is state insurance, this is private.” / “You need both.”
Don't say “BPJS itu jelek.” / “BPJS itu asuransi negara, ini private.” / “Anda butuh keduanya.”
Do say “BPJS is designed to cover hospital costs — your bed, your doctor, your medication. That’s valuable. But if you’re diagnosed with cancer or heart disease, the real cost isn’t the hospital bed — it’s the gap in your income while you’re in treatment or recovery, and the cost of specialized treatment that BPJS might not cover quickly. Sehat Seratus gives you cash in hand, fast, so your family doesn’t have to make a hard choice between treatment and rent. BPJS covers the medical side. Sehat Seratus covers the financial side.”
Do say “BPJS dirancang untuk cover biaya rumah sakit — tempat tidur, dokter, obat. Itu berharga. Tapi kalau terdiagnosa kanker atau penyakit jantung, biaya sebenarnya bukan tempat tidur rumah sakit — itu gap dalam income Anda saat sedang treatment atau recovery, dan biaya treatment specialist yang BPJS mungkin tidak cover cepat. Sehat Seratus kasih uang tunai di tangan, cepat, jadi keluarga Anda tidak harus buat pilihan sulit antara treatment dan sewa. BPJS cover sisi medis. Sehat Seratus cover sisi finansial.”
—
Objection 3: “Why does it only pay 25% for early cancer? That feels cheap.”
Customer “Kenapa hanya bayar 25% untuk kanker tahap awal? Terasa murah.”
Don't say “Because early cancer is less severe.” / “That’s the product design.” / “You can buy more sum assured.”
Don't say “Karena kanker tahap awal lebih mild.” / “Itu desain produk.” / “Anda bisa beli Uang Pertanggungan lebih besar.”
Do say “You’re thinking about this the right way. Here’s the logic: early cancer caught at stage 1 or 2 has a 85–90% five-year survival rate. The 25% payment is designed for that scenario — to cover your costs while you’re in treatment, so you don’t have to raid savings or go into debt. If your cancer progresses to stage 3 or 4, the policy jumps to 100%. So the product is saying: ‘If we catch it early, we help you manage costs without derailing your life. If it’s more serious, we pay your full sum assured.’ It’s not about cheap — it’s about tiered protection based on severity.”
Do say “Anda berfikir tentang ini dengan benar. Begini logikanya: kanker tahap awal, stage 1 atau 2, punya survival rate 85–90% lima tahun. Pembayaran 25% dirancang untuk scenario itu — cover biaya Anda saat treatment, jadi Anda tidak harus ambil saving atau hutang. Kalau kanker Anda progress ke stage 3 atau 4, polis loncat ke 100%. Jadi produk berkata: ‘Kalau kami tangkap awal, kami bantu Anda manage biaya tanpa derail hidup Anda. Kalau lebih serius, kami bayar 100%.’ Bukan tentang murah — tentang proteksi bertingkat berdasarkan severity.”
—
Objection 4: “I’m 55. Can I still buy this? The premium must be insane.”
Customer “Saya berusia 55. Saya masih bisa beli ini? Preminya pasti gila.”
Don't say “You’re at the cutoff age.” / “Premiums do go up.” / “You’re too old.”
Don't say “Anda di batas umur.” / “Premi memang naik.” / “Anda terlalu tua.”
Do say “At 55, you can still enter, but only with a 5-year payment term — meaning you pay for five years, then you’re covered to age 99 with no more premiums. Yes, the annual premium is higher than if you entered at 35. But think about it: you pay for five years and you’re done. Your family is protected for the next 44 years at zero cost. That math can work if you’re stable in income and want protection that outlives you.”
Do say “Di usia 55, Anda masih bisa masuk, tapi hanya dengan masa pembayaran 5 tahun — meaning Anda bayar lima tahun, terus tertanggung sampai usia 99 tanpa bayar lagi. Iya, premi tahunan lebih tinggi dari kalau masuk di usia 35. Tapi pikir soal ini: Anda bayar lima tahun dan selesai. Keluarga Anda terlindungi 44 tahun ke depan dengan biaya nol. Math itu bisa work kalau Anda stable di income dan mau proteksi yang outlive Anda.”
—
Objection 5: “What if I stop paying after three years? Do I lose everything?”
Customer “Kalau saya stop bayar setelah tiga tahun? Saya rugi semua?”
Don't say “Yes, you lose coverage.” / “That’s why you should commit.” / “There’s a surrender value but it’s low.”
Don't say “Ya, Anda kehilangan coverage.” / “Itulah kenapa harus commit.” / “Ada nilai tunai tapi rendah.”
Do say “If you stop paying before your paid-up term is complete, you have two options. First, the policy lapses and you lose coverage — but if you have cash value accumulated, you can take it. More importantly: when you stop paying, the insurer will send you an automatic premium loan notification. If you have enough cash value, the company will automatically cover your premiums using that cash value to keep the policy in force. So you don’t lose coverage immediately — the policy keeps running. That’s an important safety net if your income dips unexpectedly.”
Do say “Kalau Anda stop bayar sebelum masa pembayaran selesai, Anda punya dua pilihan. Pertama, polis lapsed dan Anda kehilangan coverage — tapi kalau sudah ada nilai tunai, Anda bisa ambil. Lebih penting: kalau Anda stop bayar, perusahaan asuransi akan kirim notifikasi automatic premium loan. Kalau ada cukup nilai tunai, perusahaan akan otomatis cover premi Anda pakai nilai tunai itu buat keep polis hidup. Jadi Anda tidak langsung kehilangan coverage — polis tetap jalan. Itu safety net penting kalau income Anda turun tiba-tiba.”
—
8. Compliance Red Flags & Mis-Selling Warnings
-
Pre-existing Conditions Exclusion (POJK 36/2025 alignment): The RIPLAY explicitly states that major CI, minor CI, angioplasty, ICU, and overseas treatment benefits are not paid if the condition is pre-existing or related to AIDS/HIV (except HIV-related critical illnesses listed in the policy appendix). Agents must verify underwriting responses before issuing. Do not accept vague health declarations. If a customer has existing diabetes, hypertension, or past cancer, flag for medical underwriting review before quoting. Mis-selling risk: agent quotes based on assumed health when customer has undisclosed conditions; claim is denied; customer blames agent.
-
Cancer Relapse Condition Specificity (Strict Definition): The RIPLAY states the second cancer claim (relapse benefit) requires “different histology AND pathology AND organ” from the first claim. If a customer is diagnosed with breast cancer, then ovarian cancer (different organ, same histological family), the second claim is payable. But if the second diagnosis is metastasis or recurrence of the first cancer (same histology/pathology in a new site), the relapse benefit does NOT pay. Agents must explain this limit clearly. Mis-selling risk: customer assumes “any cancer after 12 months = second claim payable” without understanding the histology requirement.
-
Vitality Program Behavioral Enforcement (Not Guaranteed Cashback): The Vitality Program cashback (Silver 2.5%, Gold 5%, Platinum 10%) is contingent on maintaining status throughout the policy year. If a customer falls below the required health activities (medical checkup, activity logging, non-smoking verification), their status drops and cashback is forfeited for that year. The discount (Year 1 only) is not conditional, but the ongoing cashback is. Do not position cashback as “guaranteed annual refund.” Frame it as “you earn cashback by staying engaged with your health plan.” Mis-selling risk: customer expects cashback in year 2 without effort, then claims agent promised automatic refund.
-
Unborn Child Rider Timing and Limits (Policy Amendment Required): The unborn child benefit requires that the child be registered as the insured within 90 days of birth, with submission of birth certificate. Benefits paid within 90 days of birth are reduced to 20% (major CI, minor CI, angioplasty, overseas treatment, ICU, death); benefits after 90 days are 100%. If the policy holder fails to register the child within the 90-day window, the rider lapses and the child is no longer covered. Agents must clarify this requirement upfront. Mis-selling risk: parent buys unborn child rider thinking automatic coverage starts at birth; child is born; parent is late registering; policy lapses; no coverage.
-
Surrender Value and Lapse Mechanics (Especially Years 1–3): The RIPLAY does not explicitly disclose a detailed surrender-value table for Sehat Seratus (unlike Allianz LegacyPro, which publishes surrender factors). Year 1–3 surrender values are expected to be low (typically 0–10% of premiums in conventional CI products). If a customer lapses in year 2 and wants to re-enter, full underwriting applies (not automatic re-acceptance). Agents must warn that early lapse recovery is difficult. Mis-selling risk: customer thinks lapse is reversible without penalty; lapses; finds re-entry requires new medical exams and possible exclusions.
-
Overseas Treatment Claim Documentation (Requires Pre-approval): The overseas cancer/heart treatment benefit requires that treatment occur within 12 months of major CI diagnosis, and covers “biaya perawatan” (treatment cost). The RIPLAY does not specify whether pre-approval from AIA is required or if reimbursement is post-treatment. Agents should advise customers to contact AIA before committing to expensive overseas treatment; failure to obtain approval may result in claim denial. Mis-selling risk: customer goes to Singapore for treatment without telling AIA, incurs Rp 500M cost, then AIA denies claim because treatment did not meet policy definition or approval requirements.
-
Accelerated vs. Non-Accelerated Benefit Confusion: The RIPLAY uses the term “benefit akselerasi” (accelerated benefit) for minor CI, angioplasty, and ICU catch-all. These benefits reduce the sum-assured pool for subsequent major CI, death, maturity, and surrender payouts. The ICU daily allowance (Rp 5M/day, max 4 days) is NOT accelerated (does not reduce pool). Agents must clarify this distinction when explaining scenarios. Mis-selling risk: customer assumes all benefits are independent; claims minor CI and ICU daily allowance; then is shocked that major CI is now worth 50% less.
9. Quick-Reference Spec Card
PRODUCT NAME
AIA Sehat Seratus
INSURER
PT AIA Financial Indonesia
CATEGORY & STRUCTURE
Critical-Illness (comprehensive
tiered; 136 conditions)
POLICY HORIZON
Issue to age 99 (open-ended)
ENTRY AGE
1 month – 60 years
(Unborn child rider: 18–45 yo mother, weeks 18–36 gestation)
PAYMENT TERMS
5, 10, or 20 years (age-dependent)
Age 1–50: 5, 10, 20 available
Age 51–55: 5, 10 available
Age 56–60: 5 available only
MIN/MAX SUM ASSURED
Min:Rp 100M
Max:Rp 3B (child 1m–17y) Rp 10B (adult 18+)
ANNUAL PREMIUM EXAMPLE
30yo, Rp 500M SA, 10-yr term: Rp 17.856M base + riders
(Vitality Year 1 discount: 5%)
MAJOR CI BENEFIT (100% payout)
77 major conditions (cancer,
stroke, MI, organ failure, etc.)
Accelerated (reduces SA pool)
Policy continues 12 months for
overseas cancer/heart treatment
MINOR CI BENEFIT (25% payout)
58 minor conditions (early cancer,
angioplasty, etc.)
Accelerated (reduces SA pool)
Max 2 claims per policy term
CANCER RELAPSE BENEFIT (25%)
Payable if second cancer differs
histologically and by organ from
first claim; min 12 months after
first minor CI claim. Max once
per policy. Accelerated.
ICU DAILY ALLOWANCE
Rp 5M per day for invasive
ventilator support, min 6 hrs
Max 4 days per ICU episode
(Rp 20M cap)
NOT accelerated (does not reduce
SA pool)
ICU CATCH-ALL BENEFIT (50%)
Rp 250M max or 50% SA,
whichever is less
Paid if ICU stay ≥5 continuous
days with ventilator
Accelerated (reduces SA pool)
Max once per policy
OVERSEAS CANCER/HEART TREATMENT
50% SA or Rp 250M max
Payable within 12 months of
major CI diagnosis (cancer or
heart only)
Requires treatment abroad
(e.g., Singapore)
DEATH BENEFIT
100% SA minus accelerated
benefits already paid
ACCIDENTAL DEATH BONUS
100% SA additional
Does NOT reduce SA pool
(separate benefit stack)
MATURITY BENEFIT (age 99)
100% SA if insured survives to
age 99 and no major CI/death
has been claimed
PREMIUM WAIVER
NOT built into base
Offered as optional Payor Benefit
riders:(a) Payor Benefit CI Waives if policyholder diagnosed with major CI (b) Payor Benefit (death/disability) Waives if policyholder dies or becomes totally disabled
VITALITY PROGRAM (OPTIONAL)
Year 1 Discount:
5-yr term: 2.5%
10-yr term: 5%
20-yr term: 7.5% Annual Cashback (depends on Vitality status at year-end):
Bronze:0%
Silver:2.5–5% (5–10yr term)
Gold:5–10% (5–10yr term)
Platinum:10–20% (5–10yr term) Status earned through health checkup, activity logging, non-smoking verification
EXCLUSIONS (RIPLAY LIST)
Death benefit not paid if:- Virus HIV - Insurance fraud - Self-harm / suicide - Aviation (except scheduled passenger flights with license) - Motor racing / speed competition CI benefits not paid if caused by: - Pre-existing conditions - AIDS/AIDS-related complex - HIV infection (except specific HIV-related CI listed in appendix)
CURRENCY
IDR only
FREE LOOK PERIOD
14 calendar days from policy
receipt
Admin fee applies if cancelled
within free look
CLAIM PROCEDURE
Download form → complete docs →
submit to AIA office → AIA
processes and notifies (SMS/letter)
→ payment
CONTACT INFO
AIA Central
Jl. Jend. Sudirman Kav. 48A,
Jakarta Selatan 12930
Phone:1500 980 or (021) 3000 1980
Email:id.customer@aia.com
Website:aia-financial.co.id
10. Action Items for Legacy Income (next 30 days)
-
Schedule product training with AIA sales rep (Week 1). Confirm policy rules on cancer-relapse histology requirement, unborn-child registration timing (90-day deadline), and overseas-treatment pre-approval process. Clarify whether automatic premium loan applies if customer stops paying in year 3. Assign one agent to attend; have them brief the team weekly for 3 weeks.
-
Develop one-pager decision tree: “Sehat Seratus vs. Allianz Critical Plus vs. TMLI TM-Critical-Guard” (Week 2). Create a side-by-side comparison of structural features (early CI payout %, cancer relapse, ICU benefit, overseas coverage, Vitality incentive, minimum premium). Use for agent coaching on objection handling. Laminate and post in sales office.
-
Build Vitality cashback calculator and scenario card (Week 2). Customer enters age, SA, payment term, Vitality status → shows Year 1 discount, annual cashback range, effective annual net cost over 10/20 years. Share with agents as conversation tool during proposal stage. Test with 3 sample customers.
-
Record product pitch video (30–60 sec EN + 30–60 sec ID) for WhatsApp / Instagram Stories (Week 3). Focus on the overseas-treatment unique feature and cancer-relapse mechanic. Target audience: affluent women 35–50 with cancer anxiety. Share with 5 test customers; gather feedback on messaging clarity.
-
Establish first-month target: Close 3 Sehat Seratus policies (Week 4). Primary targets: customers who already own Allianz health insurance and are price-sensitive to critical-illness add-ons, or HNW customers with overseas medical access intent. Qualify on Vitality Program readiness (health-conscious, organized, digital-comfortable) to maximize cashback perception. Track premium size, SA, and payment term in CRM.
This brief is generated by AI and may contain mistakes. Please exercise discretion. It is intended as an internal user training and positioning resource, not as a customer-facing sales document. All statements about the product are reconstructed from the official RIPLAY and brochure as downloaded 2026-04-29; the policy itself is the binding document. Compliance disclosures, competitor comparisons, and customer-fit guidance reflect analyst judgment and should be reviewed by user before being deployed in agent training materials.
Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.